TABLE 2.
Baseline characteristics of all dosed subjects1
| Capsinoids (n = 37) | Placebo (n = 38) | |
| Age (y) | 43 ± 82 | 41 ± 8 |
| Females (%) | 51.4 | 52.6 |
| Body weight (kg) | 88.9 ± 13.3 | 84.7 ± 12.5 |
| BMI (kg/m2) | 30.6 ± 2.4 | 30.3 ± 2.4 |
| Waist girth (cm) | 104 ± 7 | 101 ± 8 |
| Total fat (%) | 37.1 ± 7.4 | 36.8 ± 7.4 |
| Abdominal fat (%) | 41.9 ± 6.3 | 39.6 ± 6.7 |
| REE (kcal/d) | 1811 ± 216 | 1753 ± 172 |
| Fat oxidation (mg/min) | 59 ± 40 | 53 ± 24 |
1
Dosed subjects are those subjects who received at least one dose of study drug. REE, resting energy expenditure. No significant group differences were observed (t test).
2
Mean ± SD (all such values).